Breaking News, Collaborations & Alliances

HD Biosciences Enters Anti-cancer R&D Alliance

Aims to develop and commercialize drugs targeting international and Chinese markets

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

HD Biosciences Co., Ltd. (HDB), the Marshall Institute for Interdisciplinary Research (MIIR), and the Marshall University Joan C. Edwards School of Medicine, have entered partnership to co-develop anti-cancer drugs.   The partners will share discovery and development costs and will jointly own intellectual property and commercialization rights for any products developed under the collaboration. HDB will take lead compounds discovered by Marshall University to preclinical development. The partner...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters